VitaPCR™ to be Launched at the AACC Clinical Expo
Credo Diagnostics Biomedical Pte. Ltd., a groundbreaking point-of-care rapid molecular diagnostic company, announced today they will introduce their new molecular diagnostic platform, VitaPCR™, and its Influenza A/B assay, at the 71st AACC Clinical Expo that will take place in Anaheim on 6th, 7th, and 8th August 2019. Based on real-time polymerase chain reaction (real-time PCR), […]
